Taken together, our data suggest a role of Hoxc9 in the development of obesity and the determination of fat depot-specific signatures, which may affect whole body glucose metabolism, insulin sensitivity, and energy expenditure. This evidence concerns the gene HOXC9 and obesity due to melanocortin 4 receptor deficiency.